4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000122
Chief Medical Officer sold 1,989 shares at an average $37.53 ($74,642)
- Chief Medical Officer acquired 1,989 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,489 | $25.01 | $37,240 | 56,134 | D |
| 2026-10-21 | Sale : show line 2 in the form 10b5-1 | −1,489 | $37.53 | $55,882 | 54,645 | D |
| 2026-10-22 | Exercise or conversion : show line 3 in the form 10b5-1 | +500 | $25.01 | $12,505 | 55,145 | D |
| 2026-10-22 | Sale : show line 4 in the form 10b5-1 | −500 | $37.52 | $18,760 | 54,645 | D |
| Open-market sales · 1,989 sh · avg $37.53 · $74,642 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-21 | Exercise or conversion : show line 5 in the form 10b5-1 Stock options (right to buy) | −1,489 | 24,641 | D |
| 2026-10-22 | Exercise or conversion : show line 6 in the form 10b5-1 Stock options (right to buy) | −500 | 24,141 | D |
Loading xslF345X06/wk-form4_1792785942.xml…